Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Prepaid Assets (2016 - 2025)

Syndax Pharmaceuticals has reported Prepaid Assets over the past 11 years, most recently at $13.5 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $13.5 million for Q4 2025, up 957.68% from a year ago — trailing twelve months through Dec 2025 was $13.5 million (up 957.68% YoY), and the annual figure for FY2025 was $13.5 million, up 957.68%.
  • Prepaid Assets for Q4 2025 was $13.5 million at Syndax Pharmaceuticals, up from $9.5 million in the prior quarter.
  • Over the last five years, Prepaid Assets for SNDX hit a ceiling of $13.5 million in Q4 2025 and a floor of $35000.0 in Q1 2025.
  • Median Prepaid Assets over the past 5 years was $1.5 million (2023), compared with a mean of $3.0 million.
  • Biggest five-year swings in Prepaid Assets: surged 3472.35% in 2024 and later tumbled 99.42% in 2025.
  • Syndax Pharmaceuticals' Prepaid Assets stood at $642000.0 in 2021, then rose by 7.79% to $692000.0 in 2022, then plummeted by 76.45% to $163000.0 in 2023, then soared by 682.82% to $1.3 million in 2024, then surged by 957.68% to $13.5 million in 2025.
  • The last three reported values for Prepaid Assets were $13.5 million (Q4 2025), $9.5 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.